Marex Financial Statements From 2010 to 2025

MRX Stock   34.90  2.18  5.88%   
Marex Group financial statements provide useful quarterly and yearly information to potential Marex Group plc investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Marex Group financial statements helps investors assess Marex Group's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Marex Group's valuation are summarized below:
Marex Group plc does not presently have any fundamental ratios for analysis.
Check Marex Group financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Marex Group's main balance sheet or income statement drivers, such as , as well as many indicators such as . Marex financial statements analysis is a perfect complement when working with Marex Group Valuation or Volatility modules.
  
Check out the analysis of Marex Group Correlation against competitors.

Marex Group plc Company Return On Asset Analysis

Marex Group's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.

Return On Asset

 = 

Net Income

Total Assets

More About Return On Asset | All Equity Analysis

Current Marex Group Return On Asset

    
  0.0104  
Most of Marex Group's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Marex Group plc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
Competition

Based on the latest financial disclosure, Marex Group plc has a Return On Asset of 0.0104. This is 102.21% lower than that of the Capital Markets sector and significantly higher than that of the Financials industry. The return on asset for all United States stocks is 107.43% lower than that of the firm.

Marex Group plc Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Marex Group's current stock value. Our valuation model uses many indicators to compare Marex Group value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Marex Group competition to find correlations between indicators driving Marex Group's intrinsic value. More Info.
Marex Group plc is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in return on asset category among its peers reporting about  0.04  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Marex Group plc is roughly  23.91 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Marex Group's earnings, one of the primary drivers of an investment's value.

About Marex Group Financial Statements

Marex Group investors use historical fundamental indicators, such as Marex Group's revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Marex Group. Please read more on our technical analysis and fundamental analysis pages.
Medicis Pharmaceutical Corporationration, a specialty pharmaceutical company, engages in the development and marketing of various solutions for the treatment of dermatological and aesthetic conditions in the United States and Canada.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Marex Stock Analysis

When running Marex Group's price analysis, check to measure Marex Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Marex Group is operating at the current time. Most of Marex Group's value examination focuses on studying past and present price action to predict the probability of Marex Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Marex Group's price. Additionally, you may evaluate how the addition of Marex Group to your portfolios can decrease your overall portfolio volatility.